PIM
BIVV

Provident Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Provident Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-430,732
Closed -$23.2M – 59
2017
Q4 		$23.2M Buy
430,732
+9,164
+2% +$501K 3.71% 17
2017
Q3 		$24.1M Buy
421,568
+103,948
+33% +$6.09M 4.08% 15
2017
Q2 		$19.1M Buy
317,620
+50,997
+19% +$2.9M 3.48% 16
2017
Q1 		$14.5M Buy
+266,623
New +$13.1M 2.7% 20

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Provident Investment Management's BIVV Position: Q1 2018 in Review

Provident Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 430,732 shares — an estimated $23.2M sold.

Provident Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $24.1M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Provident Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Provident Investment Management sold 430,732 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $23.2M.
  • Provident Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Provident Investment Management's Bioverativ Inc. Common Stock position peaked at $24.1M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Provident Investment Management's 13F filing for Q1 2018, filed 23 Apr 2018.